High-dose-rate brachytherapy for vaginal rhabdomyosarcoma using a personalized mold in a 20-month old patient Academic Article uri icon

Overview

MeSH Major

  • Brachytherapy
  • Precision Medicine
  • Rhabdomyosarcoma
  • Vaginal Neoplasms

abstract

  • Treatment of vaginal rhabdomyosarcoma (RMS) with conservative approaches is presently the standard of care. Intravaginal high-dose rate brachytherapy is a very effective treatment while sparing the normal tissue to preserve growth, fertility and prevent organ dysfunction. In this report, we describe the management of an infant with Stage I vaginal RMS, treated with chemotherapy, maximal safe resection and intravaginal brachytherapy using a customized mold and MRI and CT-based three-dimensional (3D) conformal planning, followed by a critical review of the literature.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/pbc.25252

PubMed ID

  • 25284601

Additional Document Info

start page

  • 531

end page

  • 2

volume

  • 62

number

  • 3